Successful Treatment of New-Onset Pediatric Nephrotic Syndrome With Rituximab as a First-Line Therapy

Detalles Bibliográficos
Autores principales: Zhang, Xiaojing, Jin, Yanyan, Li, Qiuyu, Xie, Yi, Liu, Fei, Huang, Guoping, Chen, Junyi, Fu, Haidong, Wang, Jingjing, Shen, Huijun, Mao, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727513/
https://www.ncbi.nlm.nih.gov/pubmed/36506238
http://dx.doi.org/10.1016/j.ekir.2022.10.016
_version_ 1784845039614033920
author Zhang, Xiaojing
Jin, Yanyan
Li, Qiuyu
Xie, Yi
Liu, Fei
Huang, Guoping
Chen, Junyi
Fu, Haidong
Wang, Jingjing
Shen, Huijun
Mao, Jianhua
author_facet Zhang, Xiaojing
Jin, Yanyan
Li, Qiuyu
Xie, Yi
Liu, Fei
Huang, Guoping
Chen, Junyi
Fu, Haidong
Wang, Jingjing
Shen, Huijun
Mao, Jianhua
author_sort Zhang, Xiaojing
collection PubMed
description
format Online
Article
Text
id pubmed-9727513
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97275132022-12-08 Successful Treatment of New-Onset Pediatric Nephrotic Syndrome With Rituximab as a First-Line Therapy Zhang, Xiaojing Jin, Yanyan Li, Qiuyu Xie, Yi Liu, Fei Huang, Guoping Chen, Junyi Fu, Haidong Wang, Jingjing Shen, Huijun Mao, Jianhua Kidney Int Rep Letter to the Editor Elsevier 2022-10-22 /pmc/articles/PMC9727513/ /pubmed/36506238 http://dx.doi.org/10.1016/j.ekir.2022.10.016 Text en © 2022 Published by Elsevier Inc. on behalf of the International Society of Nephrology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Zhang, Xiaojing
Jin, Yanyan
Li, Qiuyu
Xie, Yi
Liu, Fei
Huang, Guoping
Chen, Junyi
Fu, Haidong
Wang, Jingjing
Shen, Huijun
Mao, Jianhua
Successful Treatment of New-Onset Pediatric Nephrotic Syndrome With Rituximab as a First-Line Therapy
title Successful Treatment of New-Onset Pediatric Nephrotic Syndrome With Rituximab as a First-Line Therapy
title_full Successful Treatment of New-Onset Pediatric Nephrotic Syndrome With Rituximab as a First-Line Therapy
title_fullStr Successful Treatment of New-Onset Pediatric Nephrotic Syndrome With Rituximab as a First-Line Therapy
title_full_unstemmed Successful Treatment of New-Onset Pediatric Nephrotic Syndrome With Rituximab as a First-Line Therapy
title_short Successful Treatment of New-Onset Pediatric Nephrotic Syndrome With Rituximab as a First-Line Therapy
title_sort successful treatment of new-onset pediatric nephrotic syndrome with rituximab as a first-line therapy
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727513/
https://www.ncbi.nlm.nih.gov/pubmed/36506238
http://dx.doi.org/10.1016/j.ekir.2022.10.016
work_keys_str_mv AT zhangxiaojing successfultreatmentofnewonsetpediatricnephroticsyndromewithrituximabasafirstlinetherapy
AT jinyanyan successfultreatmentofnewonsetpediatricnephroticsyndromewithrituximabasafirstlinetherapy
AT liqiuyu successfultreatmentofnewonsetpediatricnephroticsyndromewithrituximabasafirstlinetherapy
AT xieyi successfultreatmentofnewonsetpediatricnephroticsyndromewithrituximabasafirstlinetherapy
AT liufei successfultreatmentofnewonsetpediatricnephroticsyndromewithrituximabasafirstlinetherapy
AT huangguoping successfultreatmentofnewonsetpediatricnephroticsyndromewithrituximabasafirstlinetherapy
AT chenjunyi successfultreatmentofnewonsetpediatricnephroticsyndromewithrituximabasafirstlinetherapy
AT fuhaidong successfultreatmentofnewonsetpediatricnephroticsyndromewithrituximabasafirstlinetherapy
AT wangjingjing successfultreatmentofnewonsetpediatricnephroticsyndromewithrituximabasafirstlinetherapy
AT shenhuijun successfultreatmentofnewonsetpediatricnephroticsyndromewithrituximabasafirstlinetherapy
AT maojianhua successfultreatmentofnewonsetpediatricnephroticsyndromewithrituximabasafirstlinetherapy

Ejemplares similares